Evidence map›Paper›PMID 33068181›Full record

ArticleCancer causes & control : CCC2021

Commentary: 20 years online with "Your Disease Risk".

Graham A Colditz, Hank Dart

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer causes & control : CCC, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05332639 (Personalized Risk Estimation for Crohn's Disease), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05332639 narecruitingnot on this mapstarted 2025, after this paper: background citation

Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility

TypeinterventionalSponsorMassachusetts General HospitalRan2025 to 2027Enrolled80ConditionsInflammatory Bowel Diseases, Crohn Disease, Crohn Colitis, Crohn's IleocolitisArmsPersonalized Risk Estimation for Crohn's Disease (PRE-Crohn's) tool, Standard Crohn's Disease Education
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Graham A ColditzDivision of Public Health Sciences and Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, Washington University in St. Louis, 660 South Euclid Avenue, Campus, Box 8100, St. Louis, MO, 63110, USA.ORCID https://orcid.org/0000-0002-7307-0291
Hank DartDivision of Public Health Sciences and Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, Washington University in St. Louis, 660 South Euclid Avenue, Campus, Box 8100, St. Louis, MO, 63110, USA. hankdart@wustl.edu.ORCID http://orcid.org/0000-0002-2668-5920

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Your Disease Risk tool ( yourdiseaserisk.wustl.edu ) went live to the public in January 2000 and was one of the first personalized health risk assessment sites on the Internet. Its launch marked the culmination of years of work by a large, multi-disciplinary university team whose primary goal was to translate the science on cancer prevention into accurate, engaging, and useful messages for the public. Today, 20 years on, Your Disease Risk has expanded from its initial four cancers to include 18 different tools designed for today's users. This commentary reviews important moments and lessons learned in the first two decades of Your Disease Risk.

Indexed as

Internet-Based InterventionRisk AssessmentHumansNeoplasmsRisk FactorsApplicationCommentaryPreventionRisk assessmentRisk communicationTranslational medicine

Identifiers

PMID33068181
PMCPMC7796866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.